These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 11120034)
1. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs. Vathsala A; Chin YM; Noraiza I; Sun L Transplant Proc; 2000 Nov; 32(7):1992-4. PubMed ID: 11120034 [No Abstract] [Full Text] [Related]
2. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes. Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382 [No Abstract] [Full Text] [Related]
3. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506. Nakajima H; Oka T Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224 [No Abstract] [Full Text] [Related]
4. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro. Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317 [No Abstract] [Full Text] [Related]
5. Cyclosporine and anti-CD3 blockade of lymphocyte apoptosis induced by cytomegalovirus antigens. Briceño J; De la Torre-Cisneros J; Sanchez-Guijo P; Pera-Madrazo C Transplant Proc; 1999; 31(1-2):1370. PubMed ID: 10083607 [No Abstract] [Full Text] [Related]
6. Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferation. Haczku AF; Kay AB; Corrigan CJ Int J Immunopharmacol; 1996 Jan; 18(1):45-51. PubMed ID: 8732432 [TBL] [Abstract][Full Text] [Related]
7. Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo. Carpenter PA; Tso JY; Press OW; Yu X; Anasetti C Transplant Proc; 2000 Nov; 32(7):1545-6. PubMed ID: 11119827 [No Abstract] [Full Text] [Related]
8. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro. Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631 [No Abstract] [Full Text] [Related]
9. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. Vathsala A; Chou TC; Kahan BD Transplantation; 1990 Feb; 49(2):463-72. PubMed ID: 1689520 [TBL] [Abstract][Full Text] [Related]
10. Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response. Nakajima H; Oka T Transplant Proc; 1997; 29(1-2):1096-100. PubMed ID: 9123217 [No Abstract] [Full Text] [Related]
11. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells. Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900 [TBL] [Abstract][Full Text] [Related]
12. Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. Moutabarrik A; Nakanishi I; Takahara S; Hachim K; Bengahnem MG; Ramadani B; Ishibashi M; Zaid D Transpl Int; 1994; 7 Suppl 1():S552-5. PubMed ID: 11271305 [TBL] [Abstract][Full Text] [Related]
13. Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. Mathieu C; Bouillon R; Rutgeerts O; Vandeputte M; Waer M Transplant Proc; 1994 Dec; 26(6):3130. PubMed ID: 7527950 [No Abstract] [Full Text] [Related]
14. Augmentation of T-cell apoptosis by immunosuppressive agents. Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412 [TBL] [Abstract][Full Text] [Related]
15. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Müller TF; Grebe SO; Neumann MC; Heymanns J; Radsak K; Sprenger H; Lange H Transplantation; 1997 Nov; 64(10):1432-7. PubMed ID: 9392307 [TBL] [Abstract][Full Text] [Related]
16. Assessment of immunosuppression by lymphocyte functions in human blood. Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640 [No Abstract] [Full Text] [Related]
18. [The immunomodulating action of cyclosporin A in vitro and in vivo on the lymphocytes of patients with alveolitis]. Kosmiadi GA; Abramova ZP; Vaneeva TV; Fomina NM; Gergert VIa; Shmelev EI Probl Tuberk; 1996; (4):51-3. PubMed ID: 9026809 [TBL] [Abstract][Full Text] [Related]
19. Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. Woo J; Zeevi A; Yao GZ; Strednak J; Todo S; Thomson AW Transplant Proc; 1991 Dec; 23(6):2939-40. PubMed ID: 1721319 [No Abstract] [Full Text] [Related]
20. Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals. Willems F; Andris F; Abramowicz D; Piérard G; Wissing M; Leo O; Goldman M Transplant Proc; 1995 Feb; 27(1):1425-7. PubMed ID: 7878934 [No Abstract] [Full Text] [Related] [Next] [New Search]